External reference pricing goes global
This article was originally published in Scrip
Do you know how drug prices are set in Guam, Kiribati or Micronesia? Or whether countries like Bhutan, Papua New Guinea and Uzbekistan use external reference pricing (ERP)? If not, you're in good company. The World Health Organization and Health Action International have no idea either, and have asked people living in 39 countries around the world to let them know whether they operate any kind of drug pricing systems, and if so whether these include ERP.
You may also be interested in...
The need to accelerate clinical trials of products for treating and preventing coronavirus has led the EU authorities to propose a more streamlined process for allowing the release of GMO-containing investigational medicinal products into the environment.
The UK’s departure from the EU imposes a number of requirements on sponsors running EU trials, but it seems that many have still not taken steps to fall into line.
As the US firm prepares to ramp up production of the antiviral for use in coronavirus patients, a debate is growing over whether changes could be made to EU rules that prevent the importation of generic drugs produced under a compulsory license.